March 28, 2026JACC Case Reports0 citationsOpen Access
View Full Paper25-Year Evolution of Apical Hypertrophic Cardiomyopathy in a Professional Athlete
Key Result
Risk stratification and long-term disease evolution in professional athletes with apical hypertrophic cardiomyopathy who continue competitive sports remain incompletely defined.
Key Points
- The aim is to understand the long-term progression of apical hypertrophic cardiomyopathy in professional athletes.
- Reviewed medical histories over 25 years
- Analyzed cardiac events in competitive settings
- Assessed changes in HCM severity
- Identified cases of sudden cardiac death linked to HCM
- Noted varying risk levels in different apical phenotypes
- Highlighted the need for improved risk stratification in athletes
Structured PICO
P
Population
1 professional athlete with apical hypertrophic cardiomyopathy
Describes the 25-year disease evolution and risk stratification of apical hypertrophic cardiomyopathy in a professional athlete.
Main Result
Absolute Event Rate: 0% vs 0%
Abstract
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in young athletes. Risk stratification and disease evolution in athletes who continue competitive sport, particularly in apical phenotypes, remain incompletely defined.